Shun Hwa

Shun Hwa Biotech is a Taiwan-based pharmaceutical company that specializes in the marketing and distribution of specialty generic medicines. Founded in 1973 and currently operating as a subsidiary of Lotus Pharmaceutical, the company has built a strong reputation in therapeutic areas such as oncology, central nervous system (CNS) disorders, and cardiovascular health. Shun Hwa leverages its extensive local network and regulatory expertise to provide high-quality, affordable healthcare solutions to hospitals and clinics across Taiwan. The company's portfolio includes a wide range of prescription drugs, many of which are manufactured by its parent organization or through strategic partnerships within the Alvogen group. As a key commercial arm for its parent company, Shun Hwa plays a critical role in expanding the availability of essential medicines in the Asia-Pacific region.